We’re excited to announce the interim results of our Octopus trial. Alpha-lipoic acid showed early promise as a treatment for progressive MS, but metformin did not.
Octopus is our clinical trial for primary and secondary progressive MS. Its multi-arm, multi-stage design means that partway through the trial, the team can get a sneak preview of whether each drug looks promising. This is called the interim analysis.
You can read more about this on our website: Alpha-lipoic acid moves to next stage of Octopus trial | MS Society.
And a huge thank you to anyone who’s on the Forum that may have been involved. None of this would have been possible without you.
x